0000950170-24-055795.txt : 20240508
0000950170-24-055795.hdr.sgml : 20240508
20240508163224
ACCESSION NUMBER: 0000950170-24-055795
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240506
FILED AS OF DATE: 20240508
DATE AS OF CHANGE: 20240508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Khayal Tamer I
CENTRAL INDEX KEY: 0001430462
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38891
FILM NUMBER: 24926752
MAIL ADDRESS:
STREET 1: TRANSMEDICS INC
STREET 2: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TransMedics Group, Inc.
CENTRAL INDEX KEY: 0001756262
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
BUSINESS PHONE: 9785520900
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
4
1
ownership.xml
4
X0508
4
2024-05-06
0001756262
TransMedics Group, Inc.
TMDX
0001430462
Khayal Tamer I
C/O TRANSMEDICS GROUP, INC.
200 MINUTEMAN ROAD
ANDOVER
MA
01810
false
true
false
false
Chief Commercial Officer
true
Common Stock
2024-05-06
4
M
false
5839
66.10
A
15631
D
Common Stock
2024-05-06
4
S
false
5839
130.07
D
9792
D
Common Stock
11051
I
By the Tamer Ibrahim Ahmed Khayal Trust
Stock Option (Right to Buy)
66.10
2024-05-06
4
M
false
5839
0.00
D
2033-02-20
Common Stock
5839
14183
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $130.00 to $130.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027.
By: /s/ Stephen Gordon, Attorney-in-Fact
2024-05-08